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ABSTRACT
Objective: While vaccination in pregnancy has the potential to dramatically impact maternal and
infant morbidity and mortality, uptake of recommended vaccinations in pregnancy remains low.
Our objective was to identify barriers and facilitators of vaccination during pregnancy in Canada.
Methods: The MEDLINE database, as well as the table of contents of four relevant Canadian
journals were screened to identify all studies that considered barriers and/or facilitators to
vaccination during pregnancy, specifically in Canadian settings. Citations were screened and a
narrative synthesis of findings was undertaken given the heterogeneity of study design.
Results: In total, 17 studies met inclusion criteria, most with a focus on the seasonal and
pandemic influenza vaccines. Facilitators and barriers were identified at the level of the patient
and the provider. At both levels, knowledge was an important facilitator of vaccine acceptance
during pregnancy and was notably improved in studies following the 2009 pandemic H1N1
influenza compared to earlier studies. Vaccine endorsement by a prenatal care provider and
clear messages of safety for the fetus emerged as key motivators. Few studies addressed system
level barriers or interventions for improving vaccine uptake during pregnancy in the Canadian
setting.
Conclusions: Common themes have emerged from the Canadian literature addressing barriers
and facilitators of vaccination during pregnancy. However, there is a paucity of literature to
suggest strategies to improve the uptake of vaccination during pregnancy in Canadian settings.
Further research is urgently needed given the expanding role of vaccination during routine
prenatal care.
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INTRODUCTION

Vaccination in pregnancy has the potential to dramatically impact maternal and infant morbidity
and mortality. A prime example is the widespread introduction of routine tetanus vaccination
during pregnancy throughout the developing world, which led to a 93% reduction in maternal
and neonatal tetanus over the last quarter century1. More recently, in developed nations the
influenza and acellular pertussis (Tdap) vaccines have become the focus of maternal vaccination
initiatives2, and new vaccines in development (e.g. for Respiratory Syncytial Virus, Group B
Streptococcus) may eventually be recommended in pregnancy. Currently in Canada, the
influenza vaccine is recommended for all pregnant individuals. As of March 2018 Tdap is also
recommended by the National Advisory Committee on Immunization3 for all pregnant
individuals in every pregnancy. However in Canada, for reasons that remain unclear, uptake of
these vaccinations has been limited relative to comparator countries,.
Provincial/territorial estimates for influenza vaccine coverage during pregnancy are not
calculated for all Canadian jurisdictions, but where available, estimates of the proportion of
women vaccinated against the influenza during pregnancy remain well below 50%. In Nova
Scotia, only 17.5% of pregnant women received the influenza vaccine in 2016, compared to
64.1% of adults >65 years4. Comparable rates of influenza vaccine uptake were seen among
pregnant women in Alberta in 2014-2015 with a 14.58% rate of uptake compared to 62.39%
uptake among seniors and 34.9% uptake for children aged 6-23 months5. In contrast, populationbased estimates from other developed countries suggest uptake rates of 26% in England6 and as
high as 40-50% in Australia,7,8 Ireland9 and the United States10.
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The contrast between rates of influenza vaccine coverage for pregnant women in Canada
compared to those of pregnant women in similarly-resourced countries is striking, leading to
questions regarding the barriers and facilitators for vaccination in pregnancy in the Canadian
context. MacDougall and Halperin11 conducted a scoping review of barriers and facilitators to
uptake of maternal immunization internationally, finding influences at the patient-level (e.g.,
vaccine knowledge, perceived disease severity, concern over vaccine safety), health care
provider-level (e.g., age, specialty, practice type, and vaccine attitudes), and systems-level (e.g.,
costs, reimbursement methods, and IT infrastructure). The current analysis builds on the work
by MacDougall and Halperin to systematically conduct a more comprehensive review of
empirical research on vaccination in pregnancy specifically in Canadian settings, with the
objective of identifying factors that prevent or facilitate vaccination of pregnant individuals in
Canada.
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METHODS
This study systematically reviewed empirical research that identified barriers and facilitators to
vaccination in pregnancy among Canadian populations.
Search Strategy
We sought peer-reviewed studies in French or English that used any empirical research method
to identify barriers and/or facilitators to vaccination in pregnancy in Canadian settings. Prior to
2001 publically funded provincial programs for influenza vaccine were rare, and Canadian
recommendations to include pregnant individuals in influenza vaccination programs have been
issued in subsequent years; therefore we sought studies published 2001-2017. Studies were
identified through a combination of electronic database searching, searches of key Canadian
journals of interest, by hand-searching reference lists of included articles for additional citations,
and by consulting Canadian immunization experts for assistance identifying any studies the
previous methods failed to find.
We searched the MEDLINE database using the Ovid interface on July 11, 2017, by combining
MeSH terms for vaccines, vaccination, and immunization with pregnancy and with Canada (all
exploded to include all relevant subheadings; see Appendix for search detail).1 Searches were
conducted by author VP in consultation with author DG, an MLIS-qualified information scientist
with expertise in health services and policy reviews. Results were limited to articles focusing on
humans that were written in English or French and published in 2001 or after. We electronically
searched the contents of the four Canadian journals most likely to publish peer reviewed studies

1

An additional pilot search of the CINAHL nursing database did not result in unique relevant citations; therefore
we did not export and assess these results with the others.
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of vaccination in pregnancy (Journal of Obstetrics & Gynaecology Canada, Canadian Medical
Association Journal, Canadian Family Physician, and Canadian Journal of Public Health). We
then identified additional citations by asking experts on the topic for any missing Canadian
literature, and through hand-searching the reference lists of identified articles on the topic.
Inclusion and Exclusion Criteria
Studies eligible for inclusion focused wholly or in part on a Canadian population and on
vaccination in pregnancy, were peer-reviewed, published in 2001 or later in English or French,
and identified, attempted to address, or otherwise studied barriers to or facilitators of vaccination
in pregnancy, using any empirical research method. Studies that did not identify or address
patient, provider, or system barriers and/or facilitators to vaccination of pregnant individuals in
Canada were excluded from the study, as were commentaries, review articles without metaanalysis, clinical guidelines, cost-effectiveness analyses and studies that focused on outcomes of
vaccination in pregnancy.
Citation Screening
Citations identified though our searches were exported to an EndNote database. After deduplication, titles and abstracts were screened and articles that did not meet inclusion criteria
were excluded. All potentially-includable articles were obtained in full text and read to ensure
that they met inclusion criteria, and any that did not were discarded prior to data extraction and
analysis. Two authors assessed all studies for inclusion (VP and DG) and any disagreements
about eligibility were decided by the third author (EC). See Figure 1 for PRISMA Flow
Diagram of the search and screening process.
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Figure 1. Prisma Diagram of Search and Screening Process

Data Analysis
Data was abstracted from included studies using Microsoft Excel, within which studies were
characterized according to their year of publication, population attributes, research method(s),
vaccine(s) under study, and whether the study addressed barriers and/or facilitators at the patient,
population or system level. Given the heterogeneity of study design among the studies,
8

statistical meta-analysis was not possible; therefore we conducted a narrative synthesis of factors
at each level.
RESULTS
A total of 57 studies were identified through the MEDLINE search and 107 were identified by
searching journal contents. After de-duplication, this totaled 140 unique citations, which were
winnowed to 15 by screening title and abstract. An additional 6 studies were identified through
hand-searching the reference lists of published articles and by asking experts on the topic for any
missing Canadian literature. Figure 1 depicts the flow of citations through the different stages of
this review, including reasons for excluding 4 of these 21 full text documents. In total, 17 studies
met inclusion criteria. These included studies are summarized in Table 1.
Author, Date

Data
Year

Vaccine

Bettinger, 2016

20102011

Seasonal
influenza
immunization

Brien 2012

2009

Desjardins 2017

2015

Study
Methods

Setting

Population

Barriers /
Facilitators

Limitations

Pre/post
survey; focus
groups

Greater
Vancouver,
British
Columbia

34 pregnant
and
postpartum
women
recruited from
obstetric
waiting rooms

Possible
selection bias
(rate of refusal
58%); large
proportion of
patients were
of high
socioeconomic
means and
highly
educated
compared to
the general
Canadian
population.

Pandemic
influenza
immunization

Cross-sectional
study using
population data

Montreal,
Quebec

Denominator
of 19,490
pregnant
women

Patient level:
+ perception of
disease severity
+ perception of
disease
susceptibility for
self and infant
+ perceived
benefit of
vaccination
- omission bias
- ‘natural’
ideology
+ decisiveness
about vaccination
+ health care
provider
recommendation
Patient level:
social
deprivation

Seasonal
influenza
immunization

Survey of
prenatal care
providers

Quebec

344 prenatal
care providers

Provider level:
+ provider age
>40 years
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Limited
information
specific to
coverage
among
pregnant
women
Possible
selection bias
(37% response
rate). Possible
information

+ higher
prenatal clinical
volume
+ academic
practice
+/- differences
between
professions

bias (selfreported data.

Fabry 2011

2010

Pandemic
influenza
immunization

Cross-sectional
survey

Sherbrooke,
Quebec

250 pregnant
or postpartum
women

Patient level:
+/- trimester of
pregnancy
+ education
through
government
websites
+ belief in the
efficiency of
vaccine
+
recommendation
from health
professional

Risk of
selection bias
is low (refusal
rate 5.2%).
Possible
information
bias secondary
to selfreported
vaccination
status.

Gracie 2011

2011

Pandemic
influenza
immunization

Cross-sectional
survey

Calgary,
Alberta

509 pregnant
women

Patient level:
+ higher
household
income
+ higher
education
+ planned
pregnancy

Halperin 2014

20052006
and
2011

Seasonal
influenza
immunization

Cross-sectional
survey at time
points pre- and
post-H1N1

Halifax,
Nova Scotia

821 pregnant
women

Patient level:
+ enhanced
knowledge about
influenza and
vaccinations
post-pandemic
+ higher
education
+ higher
socioeconomic
status
+
recommendation
from a physician

Risk of
selection bias
(response rate
of 79%); large
proportion of
patients were
of high
socioeconomic
means and
highly
educated
compared to
the general
Canadian
population.
Possible
information
bias secondary
to selfreported
vaccination
status.
Possible
selection bias:
large
proportion of
patients was of
high
socioeconomic
means and
highly
educated
compared to
the general
Canadian
population.
Self-reported
vaccination
status.
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Hilderman 2011

20002008

Seasonal
influenza
immunization

Cross-sectional
study using
population data

Manitoba

All deliveries in
the province
between 20002008
(denominator
not provided)

Kowal 2015

n/a

Immunizations
during
pregnancy in
general

In-person
interviews

Edmonton,
Alberta

23 immigrant
women from
South Asia and
China

Lee 2004

2002

Seasonal
influenza
immunization

Mailed out
survey

Ontario

113 midwives
and midwifery
students

Legge 2014

20102012

Seasonal
influenza
immunization

Cross-sectional
study using
population data

Nova Scotia

12,223
pregnant
women

Liu 2012

20092010

Pandemic
influenza
immunization

Cross-sectional
study using
population data

Ontario

64,293
pregnant
women

MacDougall 2016

20082014

Tdap

Surveys
distributed in

Multiple
urban

346 pregnant
women
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Patient level:
+ family
physician as
prenatal care
provider
+ comorbid
conditions
+ higher
income
+ older
maternal age
+ child at home
<24 months
+ more
frequent prenatal
visits
Patient level:
- language
barrier for verbal
and written
information
about vaccination
+ provider
recommendation
+ family and
social networks
Provider level:
+/- year of
graduation
+ knowledge of
impact of
influenza in
pregnancy
+/- beliefs about
immunization in
general
Patient level:
+ higher
income
+/- marital
status
+ higher risk
pregnancy
rural
residence

Patient level:
+ family
physician as
prenatal care
provider
+ higher
socioeconomic
status
+ older
maternal age
+ medical
comorbidities
+ earlier
prenatal care
Patient level:

Data available
from
population
databases
provided
limited
individual level
explanations
for the
identified
trends

Possible
selection bias
in terms of
recruitment
strategy. Selfreported
vaccination
behavior not
corroborated
with rates of
uptake.
Possible
selection bias
(36-42%
response rate).
Self-reported
behavior may
present
possible
information
bias.
Data available
from
population
databases
provided
limited
individual level
explanations
for the
identified
trends
Data available
from
population
databases
provided
limited
individual level
explanations
for the
identified
trends

Possible
selection bias

conjunction
with
recruitment
into a clinical
trial

centers in
Canada
(Edmonton,
AB;
Montreal
QC;
Vancouver,
BC; Ottawa,
ON; Halifax,
NS)

+ physician
recommendation
- low
knowledge about
pertussis and the
pertussis vaccine
+ generally
favourable
attitude toward
vaccination in
pregnancy

Sakaguchi 2011

2009

Pandemic
influenza
immunization

Telephone
survey

Centre in
Toronto, ON
with
participants
from all of
Canada

130 pregnant
women
accessing
MotherRisk
services

Tong 2008

20032004

Seasonal
influenza
immunization

Cross-sectional
survey of
prenatal care
providers and
postpartum
women

Toronto,
Ontario

227 prenatal
care providers
and 185 postpartum
women

Yudin 2009a
Pregnant
Women’s
Knowledge of
Influenza and the
Use and Safety of
the Influenza
Vaccine During
Pregnancy

2006

Seasonal
influenza
immunization

Cross sectional
survey of postpartum women

Toronto,
Ontario

100
postpartum
women

Yudin 2009b
Impact of Patient
Education on
Knowledge of
Influenza and
Vaccine
Recommendations
Among Pregnant
Women

20062007

Seasonal
influenza
immunization

Cross sectional
survey of postpartum women
pre- and postimplementation
of educational
brochure

Toronto,
Ontario

Total of 400
post-partum
women (100
from 2006 and
300 from
2007)
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Patient level:
- media
provided
confusing
information
+ accessing
MotherRisk
- concern of
safety to the
fetus
Provider level:
knowledge
gaps
+/- Provider
type (FP vs. OB)
+ attitudes
toward
vaccination
Patient level:
knowledge
gaps
concern
safety to the
fetus
+
recommendation
by a physician
Patient level:
- knowledge
gaps
- vaccine
offered
infrequently
- concern for
safety to the
fetus
Patient level:
+ direct
patient education

(response rate
not listed).
Large
proportion of
patients were
of high
socioeconomic
means and
highly
educated
compared to
the general
Canadian
population..
Selection
limited to
women
accessing the
MotherRisk
services may
limit
generalizability
of conclusions
Possible
selection bias
(response rate
34-55%). Selfreported
vaccination
behavior.

Possible
selection bias
(convenience
sample).

Possible
selection bias
(convenience
sample).
Possible
information
bias secondary
to self-report
of vaccination
behavior

Yudin 2010

2007

Seasonal
influenza
immunization

Calculation of
vaccination rate
after
implementation
of clinical nurse
champion for
immunization
in prenatal
clinic

Toronto,
Ontario

n/a

Patient level:
+ dedicated
staffing to offer
prenatal
vaccination

Aggregate level
data with
limited data
points
available to
control for
confounding
when
comparing to
previous
vaccination
rates

Overview of available literature
Two of the 17 included studies had national or multicenter Canadian representation among
participants while the others had single-province participation from Nova Scotia (2), Quebec (3),
Ontario (6), Manitoba (1), Alberta (2) and British Columbia (1). Most of the available literatures
focused on the seasonal influenza vaccine (10) and the pandemic influenza H1N1 vaccine (6)
during pregnancy, with one study looking at tetanus-diphtheria-pertussis vaccination during
pregnancy. Diverse study methodologies have been employed, including cross-sectional
observational studies of population-level data (4), survey-based studies of prenatal care providers
(3), survey-based studies of pregnant or post-partum women (9) , interview and focus group
methods with pregnant and post-partum women (2), and investigations of interventions designed
to increase vaccine uptake (1).
Patient-level barriers and facilitators
Six studies12-17 reported on characteristics of patients associated with receipt or non-receipt of
vaccinations during pregnancy. Seven additional studies evaluated knowledge, attitudes, beliefs
and intended behavior of pregnant women toward immunization in pregnancy18-24. Given the
potential effect that H1N1 media coverage and response campaigns targeting pregnant women
13

may have had on uptake, we have presented studies on patient-level barriers and facilitators
separately for cohorts prior to 2009-2010 H1N1 pandemic influenza (7) and those during the
2009-2010 H1N1 pandemic or thereafter (8).
Patient-level barriers and facilitators prior to 2009-2010
Prior to the H1N1 pandemic outbreak, the literature considering patient factors, knowledge and
attitudes about the influenza vaccine during pregnancy identified knowledge gaps, especially
about vaccine safety and disease severity, as a substantial barrier to vaccination. Important
facilitators of vaccination in this period were the desire of pregnant women to protect their
infants and the recommendation of a health care provider.
Prior to the 2009-2010 pandemic influenza, the available literature indicates low uptake of the
influenza vaccine during pregnancy. A population-based cohort study from Manitoba reported a
6% rate of uptake for the influenza vaccine during pregnancy by 200815 and found low-income,
young age, fewer prenatal care visits prior to 32 weeks of gestational age to be associated with
low uptake of the influenza vaccine during pregnancy15. A Toronto-based survey of post-partum
women by Tong found in 2003-04 that 14% self-reported having received the influenza vaccine
during pregnancy22. Findings from both the population-based cohort study and the survey-based
study suggested that maternal intention to protect the infant was an important predictor for
receipt of the influenza vaccination. Tong et al found that women who knew that maternal
influenza vaccination was beneficial for their babies were more likely to have received the
influenza vaccine during pregnancy (OR 3.5, 95% CI 1.4-9)22; and Hilderman et al demonstrated
that women were more likely to have received the influenza vaccine during pregnancy if they
had had comorbidities or if they had a child at home under 24 months of age15. Similarly, the
14

Manitoba Immunization Study found that recently pregnant women were twice as likely than
pregnant women to receive the influenza vaccine15.
Knowledge gaps among pregnant individuals prior to 2009-2010 pandemic influenza were
clearly illustrated through two Toronto-based surveys22,23. Overall, knowledge was imperfect,
with respondents answering only 62% of knowledge questions correctly23. Misperception about
the safety of the influenza vaccine during pregnancy was common, with 54% of women
believing that the influenza vaccine should be avoided during pregnancy22 and over 20%
believing it was associated with birth defects23. The potential severity of influenza infection
during pregnancy was underestimated with the majority of women believing that influenza
infection for a pregnant woman carried the same risk as influenza infection for a non-pregnant
woman23. Tong et al demonstrated a positive correlation between knowledge and receipt for the
influenza vaccine22. Relevant to misconceptions of vaccine safety, survey by Yudin et al found
that 80% of women survey preferred to be vaccinated against influenza in the post-partum
period23.
The role of the health-care provider was also important in the pre-H1N1 studies. Women
receiving prenatal care from an obstetrician exclusively were less likely to be vaccinated in the
Manitoba cohort compared to women receiving care from a primary care physician. Tong et al
found that women who received a recommendation from their physician were significantly more
likely to have received the influenza vaccine during pregnancy (OR 34.5, 95%CI 10.5-119)22.
Patient-level barriers and facilitators subsequent to 2009-2010
Subsequent to the H1N1 pandemic outbreak, uptake of influenza vaccination in pregnancy
increased somewhat, and the literature considering patient factors, knowledge and attitudes about
15

the influenza vaccine during pregnancy identified that knowledge about disease severity and
vaccine safety appeared to have improved compared to prior to studies conducted H1N1.
Physician recommendation and clarity of information became increasingly cited as facilitators to
vaccination for pregnancy women.
The Canadian literature reporting on cohorts during or following the 2009-2010 H1N1 pandemic
influenza report higher rates of uptake of the influenza vaccine among pregnant women
compared to the period prior to 2009-2010. This is particularly striking for the H1N1 pandemic
influenza vaccine with self-reported rates of uptake of up 67-76%13,14,24 in Quebec, Alberta and
Nova Scotia and population-based estimates of 38% in Ontario17. Estimates of influenza vaccine
uptake during pregnancy based on self-report differ from those based on population-level data.
Post-H1N1, older maternal age, higher income, increased education and presence of medical
comorbidities continued to be associated with higher uptake of the influenza vaccine during
pregnancy14,16,17.
Type of provider continued to be associated with uptake of the influenza vaccine during
pregnancy with women in Ontario being more likely to receive the pandemic H1N1 influenza
vaccine if their prenatal care was provided by a family physician17. Survey-based studies from
the post-H1N1 time period continue to underscore the importance of physician recommendation
as a key motivator for receipt of the influenza vaccine during pregnancy13,20,24 and one surveybased study comparing cohorts pre- and post-H1N1 suggests that this was becoming an
increasingly important motivator24.
Patient concerns about safety remained the most commonly cited barrier to influenza vaccination
during pregnancy among these studies13,20, though Halperin et al found the proportion of women
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reporting that it was best to avoid all vaccinations during pregnancy declined in the period
following H1N124. Notably, appreciation for disease severity appeared increased in this time
period, with 73.1% of women in one survey-based study citing “concern about the risk of H1N1
infection in the fetus and/or themselves” to be the primary motivator for receiving the H1N1
pandemic influenza vaccine during pregnancy20.
Bettinger et al conducted focus groups and pre/post flu season surveys involving 22 women
sampled from British Columbia to understand their rationale for receipt or non-receipt of both
the seasonal influenza and the H1N1 pandemic vaccination during pregnancy18. While most of
the sample of women self-identified as being pro-vaccine and agreed that vaccines are effective
and safe for pregnant women, just half the sample agreed that they had enough information to
make a decision about being vaccinated during pregnancy. Only a minority of women reported
having had a health care provider discuss vaccination with them during pregnancy and
ambiguous information combined with aversion to ambiguity were cited as important barriers to
receipt of a vaccination during pregnancy18.
A qualitative study by Kowel et al conducted semi-structured interviews with 23 women in
Edmonton, Alberta, who had recently immigrated to Canada from South or East Asia19.
Important themes that emerged from this study were that the sample of women demonstrated
significant trust in the recommendations of health-care providers and in Canadian
recommendations about vaccination during pregnant. The majority of women did not seek
information beyond the health care provider; however, few recalled having had vaccinations
discussed by a health care provider during their pregnancy. A particularly poignant quote was
even used as the title for the study, “If they tell me to get it. I’ll get it. If they don’t…”
17

Participants in this study identified language of spoken and written information to be an
important barrier to accessing vaccine information in Canada19.
Chronologic assessment of Canadian information related to barriers to vaccination during
pregnancy at the level of the patient revealed that while knowledge about safety and disease
severity has evolved following 2009-2010 H1N1 pandemic influenza, several important barriers
persist: the need for clear and unambiguous information about safety and the necessity of a
recommendation from a prenatal care provider.
Care Provider-level barriers and facilitators
Prenatal care provider characteristics and practices that have consistently been identified as
potential barriers or facilitators to vaccination in pregnancy include provider specialty (with
patients of family doctors more likely to be vaccinated against influenza than those who received
prenatal care from an obstetrician only), provider vaccine knowledge (with higher knowledge
associated with higher likelihood of offering vaccination), and practice setting (with physicians
working in academic centres or family practices that offered other vaccinations more likely to
recommend or offer vaccination in pregnancy).
Five studies15,22,25,26 reported on characteristics of prenatal care providers (e.g. specialty, vaccine
knowledge, practices etc.). Three of these22,25,26 used survey-based designs with response rates
of 32-43%, and inquired about prenatal care provider self-reported knowledge, beliefs and
practice patterns in Ontario22,25 and Quebec26. Provider self-reports of recommendation to be
vaccinated against influenza are stable between two surveys of prenatal care providers, one prior
and the other subsequent to 2009-2010 pandemic H1N1, with 63.4%22 and 60%26 of providers
18

reporting recommending the influenza vaccine for pregnant women, respectively. However, the
most recent survey of providers in Quebec26 reports higher self-reported rates of recommending
the influenza vaccine to pregnant women for obstetricians (80% vs. 65%) and midwives (12%
vs. 8.5%) compared to previous reports22,25.
Vaccine knowledge by care providers was consistently associated with higher likelihood of
recommending the influenza vaccine during pregnancy22,25,26. An important knowledge gap
identified by two pre-H1N1 studies relates to failure to recognize that influenza could have
severe consequences for pregnant women, with 40% of obstetricians and family practitioners22
and 63% of midwives25 having answered questions on this topic incorrectly. Knowledge about
safety and efficacy were high among obstetricians and family practitioners, but low among
midwives prior to pandemic H1N122,25. Other facilitating factors associated with higher
likelihood of offering the influenza vaccine during pregnancy were a positive attitude toward the
influenza vaccine22,25 and having personally received the influenza vaccine22,25
Two studies reported provider characteristics associated with uptake of the influenza vaccine
during pregnancy using population-based data15,17. Here, information about provider
characteristics gleaned from population-based data is limited to the association between specialty
of primary prenatal care provider and uptake rate of the influenza vaccine during pregnancy.
Both of these studies demonstrate that women who have a family physician as a prenatal care
provider are significantly more likely to receive an influenza vaccine compared to who are
followed by an obstetrician alone or by a midwife during pregnancy15,17.
In summary, more recent publications suggest that at the level of the Canadian health-care
provider, there is improved knowledge about vaccinations during pregnancy as well as increased
19

adherence to guidelines for all types of prenatal care providers. However, the self-reported rates
of guideline adherence do not align with the population based estimates of actual vaccine
delivery. As such, further research is needed to identify the structural barriers that limit a
provider’s ability to recommend and deliver vaccines to pregnant women despite knowledge and
desire to do so.
System-level Barriers and Facilitators
Very few available studies reported specifically on structural barriers that affect the provider’s
ability to administer vaccines to pregnant women. However, Desjardins did identify a higher
rate of adherence to guidelines about vaccination in pregnancy for physicians working in an
academic centre (66% vs. 53%, p=0.03). Additionally, Tong et al, who found that family
physicians were more likely to recommend the influenza vaccine during pregnancy, identified
that all family physicians surveyed worked in practices that offered at least one type of vaccine,
compared to only 26% of obstetricians included in their sample.
We identified two Canadian studies that focused on interventions aiming to increase knowledge
and uptake of influenza vaccination during pregnancy27,28. In the first, distribution of an
information pamphlet about the influenza vaccine during the prenatal period resulted in increased
knowledge scores and improved vaccination rates from 19% to 56% for a cohort of post-partum
women in Toronto, ON28. The second study, also from Toronto, describes the implementation of
a “nurse champion” in the prenatal clinic setting. This intervention is characterized both by
capacity for point-of-care vaccination and by enhanced clinical staffing (the “nurse champion”)
to deliver this service. This nurse was employed for a brief two-week period and had no other
responsibilities other than to approach patients, educate, offer and administer the influenza
20

vaccine. This study reported an uptake of 42% for the influenza vaccine among the pregnant
women in this sample (n=266) compared to a 16-21% uptake rate reported for this clinic in prior
seasons. Neither study had a robust control group to quantify the magnitude of effect of the
interventions. Limitations notwithstanding, both studies from Toronto, ON were conducted prior
to 2009-2010 pandemic H1N1 influenza and the reported rates of influenza vaccine uptake
among these pregnant cohorts were considerably higher than contemporary rates of uptake
discussed above. These findings suggest that small changes in care delivery structure that aim to
inform and personally invite pregnant individuals to be vaccinated may be effective strategies.
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DISCUSSION
Although influenza vaccination is recommended for all pregnant individuals in Canada, rates of
seasonal influenza vaccine in pregnancy remain very low, especially when considered in
comparison to other similarly resourced countries. Vaccination during pregnancy is becoming a
mainstay for improving rates of maternal and neonatal morbidity and the number of vaccinations
that are indicated for use in pregnancy is likely to increase in the future.
Our review of the Canadian literature has identified barriers and facilitators to vaccination in
pregnant individuals at the level of the patient and the provider. These barriers and facilitators
are summarized in the Table 2. We also found indications that targeted outreach to pregnant
individuals may be effective in increasing vaccine knowledge and uptake. Among patients and
providers alike, improved knowledge and positive beliefs about immunization were found to be
important facilitators for immunization in pregnancy. Pregnant patients appear to be especially
motivated to be vaccinated when a recommendation is made by a prenatal care provider.
Women receiving prenatal care from family physicians were more likely to be immunized
compared to women receiving prenatal care exclusively through an obstetrician. It is likely that
system barriers (e.g, logistical ease of managing vaccine stock) influence the ability of a prenatal
care provider to deliver vaccines to prenatal patients, but to date, there are virtually no published
studies to elucidate the system barriers relevant to practitioners in Canada.
The Canadian health care system is dramatically different from that of our neighbours to the
south; therefore, when considering health services issues we cannot rely solely on evidence from
a largely privatized and highly fragmented system of delivering health care. However, the bulk
of the existing research on the question of barriers and facilitators to vaccination in pregnancy
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has been conducted in US settings. To address this knowledge gap, further research is required to
better understand patient, provider and system level barriers to maternal vaccination in Canada.
In particular, in-depth, context-sensitive methods such as ethnography, which can delve into
cultural and structural factors affecting vaccine uptake in Canadian settings, would be of great
value. Moreover, efforts to understand barriers and improve the uptake of vaccination during
pregnancy would benefit from strengthening of immunization registries in a variety of
jurisdictions arounds the country to provide comprehensive and objective estimates of vaccine
coverage.
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CONCLUSION
Even the safest and most effective vaccine is of limited use if it is not accepted by patients,
recommended by care providers and effectively delivered within the health care system.
Indications for vaccination in pregnancy are likely to expand in the coming decades; therefore,
there is an urgent need to identify determinants of vaccine acceptance and strategies to improve
the uptake of vaccinations during pregnancy that will perform well in Canadian contexts.
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Appendix A: MEDLINE search strategy
Database: Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R) 1946 to
Present
Date: 11 July, 2017
Search:
1.
2.
3.
4.
5.
6.
7.

Exp Vaccines/
209070
Exp Vaccination/
75265
Exp Immunization/
160635
Exp Pregnancy/
839743
Exp Canada/
144442
1 or 2 or 3
295774
3 and 4 and 5
112
8. Limit 6 to (humans and yr="2001 -Current" and (english or french))

27

57

